Jessica L. Mega - May 15, 2022 Form 4 Insider Report for DANAHER CORP /DE/ (DHR)

Role
Director
Signature
James F. O'Reilly, Attorney-in-Fact for Jessica L. Mega, MD, MPH
Stock symbol
DHR
Transactions as of
May 15, 2022
Transactions value $
$0
Form type
4
Date filed
5/17/2022, 05:10 PM
Previous filing
May 18, 2021
Next filing
May 17, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DHR Common Stock Award $0 +372 +29.29% $0.00 1.64K May 15, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction DHR Director stock option (right to buy) Award $0 +929 $0.00 929 May 15, 2022 Common Stock 929 $249.19 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On the date indicated, Danaher Corporation granted the reporting person restricted stock units (RSUs) in the amount indicated. Since the RSUs are payable solely in common stock, they are being reported in Table I of this Form 4. The RSUs vest on the earlier of the first anniversary of the grant date, or the date of (and immediately prior to) the next annual meeting of Danaher's shareholders following the grant date, but the underlying shares are not issued until the earlier of the director's death or the first day of the seventh month following the director's retirement from the Board.